Informations générales (source: ClinicalTrials.gov)
Pilot Study: Measure of the Potential Evoked With Electroencephalography and Electrocorticography by Electric Stimulation of the Brain During the Neurosurgery Awakened of the Infiltrative Glioma of Low Grade (OMS Type II) (PE&CE)
Interventional
N/A
University Hospital, Montpellier (Voir sur ClinicalTrials)
juillet 2015
décembre 2025
29 juin 2024
This study is about an experimental biomedical monocentric search concerning twelves
patients presenting a infiltrative glioma of low rank OMS type II and realizing a surgery
awakened on the site of the CHU of Montpellier.
The objective of this search is to understand exactly how the electric impulses,
delivered by the neurosurgeon to make a functional mapping of the brain during the
surgery awakened by tumors infiltrates of low rank, propagate in this one and to identify
the nervous networks inhibited by these electric impulses.
Having verified the eligibility of the patients and having obtained their consent, they
will be included in the study. Before the beginning of the surgery, the
electroencephalography activity of the brain of every patient will be recorded. Before
and after the surgical resection, the electrocorticography activity will be recorded.
The collected data will then be analyzed, after the operation. Analyses will try to
identify what we call potential evoked by the stimulation and which are small electric
waves which appear after the electric stimulation was delivered.
Etablissements
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| CHU de Montpellier - Service de neurochirurgie - 34000 - Montpellier - France | Hugues DUFFAU | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- Patient carrier of a low-rank infiltrative glioma (OMS Type II) and presenting the
indications to benefit from a surgical care in condition awakened for the first
time.
- Patient capable of understanding the nature, the purpose and the methodology of the
research.
- Having signed an informed consent writes before the inclusion in the research.
- Membership or beneficiary of a national insurance scheme
- Patient carrier of a low-rank infiltrative glioma (OMS Type II) and presenting the
indications to benefit from a surgical care in condition awakened for the first
time.
- Patient capable of understanding the nature, the purpose and the methodology of the
research.
- Having signed an informed consent writes before the inclusion in the research.
- Membership or beneficiary of a national insurance scheme
- Systematic pathology with neurological appearance
- Psychiatric disorders
- History of psychotic disorders
- History of cranial trauma serious (according to the classification), previous or
evolutionary other neurological pathology
- Major protected by the law (supervision or guardianship)
- Loss of liberty by court or administrative order